+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theranostics Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Theranostics Market by Product, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Theranostics Market by Product, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967551
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Theranostics Market grew from USD 2.33 billion in 2023 to USD 2.67 billion in 2024. It is expected to continue growing at a CAGR of 14.89%, reaching USD 6.18 billion by 2030.

Theranostics, a fusion of therapeutics and diagnostics, represents a paradigm shift in personalized medicine, enabling tailored treatment plans based on individual diagnostic results. The necessity for theranostics arises from the increasing demand for patient-specific treatments, driven by the growing recognition of genetic and molecular diversity in diseases like cancer. Its applications span oncology, cardiology, neurology, and infectious diseases, where precise diagnostics and targeted therapies improve patient outcomes and optimize healthcare resources. End-users of theranostics primarily include hospitals, diagnostic laboratories, and research institutions focused on advancing precision medicine.

Market growth is influenced by factors such as advancements in molecular imaging technologies, integration of artificial intelligence, and increased funding for personalized medicine research. Additionally, evolving regulatory frameworks that support personalized treatment approaches further stimulate market expansion. Notable opportunities exist in the continuous development of novel biomarkers and imaging agents, as well as expanding applications in diseases beyond oncology. Companies can capitalize on these opportunities by investing in R&D collaborations with academic institutions to accelerate innovation and market entry.

However, limitations include high costs of theranostic tools, challenges in regulatory approval processes, and the complexity of clinical trials for combined diagnostic and therapeutic products. Moreover, market growth is constrained by limited awareness and adoption in developing regions, which necessitates strategic educational initiatives and partnerships to broaden theranostics' reach.

Innovation in theranostics can be driven by focusing on the integration of advanced data analytics for precision diagnostics, development of multifunctional nanoparticles, and pursuing breakthroughs in non-invasive imaging modalities. Emphasizing robust clinical validation and cost-effectiveness can enhance adoption. The market remains dynamic, characterized by rapid technological advancements and increasing competitiveness among key players. Strategic investments in emerging technologies and fostering a cooperative ecosystem for R&D can position companies at the forefront of this transformative sector, enabling them to harness growth opportunities while navigating inherent challenges.

Understanding Market Dynamics in the Theranostics Market

The Theranostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of target diseases globally
    • Rising advancements in personalized medicine and molecular biology
  • Market Restraints
    • High costs associated with R&D and the complexity of regulatory approvals
  • Market Opportunities
    • Increasing integration of data analytics and machine learning in theranostics
    • Growing development of novel biomarkers and non-invasive imaging techniques
  • Market Challenges
    • Data privacy and the ethical considerations of personalized medicine

Exploring Porter’s Five Forces for the Theranostics Market

Porter’s Five Forces framework further strengthens the insights of the Theranostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Theranostics Market

External macro-environmental factors deeply influence the performance of the Theranostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Theranostics Market

The Theranostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Theranostics Market

The Theranostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Theranostics Market

The Theranostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Theranostics Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Ariceum Therapeutics GmbH, Astellas Pharma Inc., BAMF Health, Bayer AG, bioMérieux SA, Biosynth Ltd., Cardinal Health, Inc., Cerebral Therapeutics, Inc., Clarity Pharmaceuticals, Curasight A/S, Curium Inc., Evergreen Theragnostics, Inc., GE HealthCare Technologies, Inc., Hermes Medical Solutions AB, Icon Group, Indi Molecular, Inc., Integrated Clinical Oncology Network Pty Ltd., Invicro, LLC, Ipsen Pharma, Radiopharm Theranostics Limited, Ratio Therapeutics, Siemens Healthineers AG, SOFIE Co., Telix Pharmaceuticals Limited, and United Theranostics.

Market Segmentation & Coverage

This research report categorizes the Theranostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Product
      • Diagnostic Imaging
        • Functional Imaging
        • Molecular Imaging
        • Nuclear Imaging
      • In Vitro Diagnostics/Biomarker Screening
        • Fluorescence In Situ Hybridization
        • Next-generation Sequencing
        • Polymerase Chain Reaction
      • Radiopharmaceuticals
        • Fluorine-18
        • Gallium-68
        • lodine-131
        • Lutetium-177
        • Radium-223
        • Samarium-153
        • Strontium-89
        • Technetium-99
        • Yttrium-90
    • Services
    • Software
      • Imaging Analytics
      • Predictive Modeling
  • Application
    • Bone Metastatis
    • Cardiovascular Diseases
    • Lymphoma
    • Neuroendocrine Tumors
    • Prostate Cancer
  • End-User
    • Cancer Care Centers
    • Hospitals
    • Research & Academic Centers
    • Theranostics Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of target diseases globally
5.1.1.2. Rising advancements in personalized medicine and molecular biology
5.1.2. Restraints
5.1.2.1. High costs associated with R&D and the complexity of regulatory approvals
5.1.3. Opportunities
5.1.3.1. Increasing integration of data analytics and machine learning in theranostics
5.1.3.2. Growing development of novel biomarkers and non-invasive imaging techniques
5.1.4. Challenges
5.1.4.1. Data privacy and the ethical considerations of personalized medicine
5.2. Market Segmentation Analysis
5.2.1. Product: Rising usage of software for data acquisition, processing, and analysis
5.2.2. End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Theranostics Market, by Product
6.1. Introduction
6.2. Product
6.2.1. Diagnostic Imaging
6.2.1.1. Functional Imaging
6.2.1.2. Molecular Imaging
6.2.1.3. Nuclear Imaging
6.2.2. In Vitro Diagnostics/Biomarker Screening
6.2.2.1. Fluorescence In Situ Hybridization
6.2.2.2. Next-generation Sequencing
6.2.2.3. Polymerase Chain Reaction
6.2.3. Radiopharmaceuticals
6.2.3.1. Fluorine-18
6.2.3.2. Gallium-68
6.2.3.3. lodine-131
6.2.3.4. Lutetium-177
6.2.3.5. Radium-223
6.2.3.6. Samarium-153
6.2.3.7. Strontium-89
6.2.3.8. Technetium-99
6.2.3.9. Yttrium-90
6.3. Services
6.4. Software
6.4.1. Imaging Analytics
6.4.2. Predictive Modeling
7. Theranostics Market, by Application
7.1. Introduction
7.2. Bone Metastatis
7.3. Cardiovascular Diseases
7.4. Lymphoma
7.5. Neuroendocrine Tumors
7.6. Prostate Cancer
8. Theranostics Market, by End-User
8.1. Introduction
8.2. Cancer Care Centers
8.3. Hospitals
8.4. Research & Academic Centers
8.5. Theranostics Centers
9. Americas Theranostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Theranostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Theranostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
12.3.2. BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics
12.3.3. UCLA Health to Open Theranostics Center
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. THERANOSTICS MARKET RESEARCH PROCESS
FIGURE 2. THERANOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. THERANOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 75. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 76. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 77. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 78. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 83. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 84. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 117. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 118. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 119. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 120. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 125. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 126. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 127. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 128. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 141. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 142. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 144. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. THAILAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. THAILAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. THAILAND THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 189. THAILAND THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 190. THAILAND THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 191. THAILAND THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 192. THAILAND THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. THAILAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. DENMARK THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. DENMARK THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 214. DENMARK THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 215. DENMARK THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 216. DENMARK THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 217. DENMARK THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. DENMARK THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. EGYPT THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. EGYPT THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 222. EGYPT THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 223. EGYPT THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 225. EGYPT THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. EGYPT THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. FINLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. FINLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. FINLAND THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 230. FINLAND THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 231. FINLAND THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 233. FINLAND THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. FINLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. FRANCE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. FRANCE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. FRANCE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 238. FRANCE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 239. FRANCE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 241. FRANCE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. FRANCE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. GERMANY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. GERMANY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. GERMANY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 246. GERMANY THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 247. GERMANY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 248. GERMANY THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 249. GERMANY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. GERMANY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. ITALY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. ITALY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. ITALY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 262. ITALY THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 263. ITALY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 264. ITALY THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 265. ITALY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. ITALY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. NORWAY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. NORWAY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. NORWAY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 286. NORWAY THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 287. NORWAY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 288. NORWAY THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 289. NORWAY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. NORWAY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. POLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. POLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. POLAND THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 294. POLAND THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 295. POLAND THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 296. POLAND THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 297. POLAND THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. POLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. QATAR THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. QATAR THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. QATAR THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 302. QATAR THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 303. QATAR THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 304. QATAR THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 305. QATAR THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. QATAR THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 311. RUSSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. RUSSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 313. RUSSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. RUSSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 326. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 328. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. SOUTH AFRICA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. SPAIN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 332. SPAIN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 333. SPAIN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 334. SPAIN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 335. SPAIN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 336. SPAIN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 337. SPAIN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. SPAIN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 343. SWEDEN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 344. SWEDEN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 345. SWEDEN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. SWEDEN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 351. SWITZERLAND THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 352. SWITZERLAND THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 353. SWITZERLAND THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. SWITZERLAND THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 355. TURKEY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 356. TURKEY THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 357. TURKEY THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 358. TURKEY THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2030 (USD MILLION)
TABLE 359. TURKEY THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 360. TURKEY THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 361. TURKEY THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. TURKEY THERANOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES THERANOSTICS

Companies Mentioned

The leading players in the Theranostics Market, which are profiled in this report, include:
  • Actinium Pharmaceuticals, Inc.
  • Ariceum Therapeutics GmbH
  • Astellas Pharma Inc.
  • BAMF Health
  • Bayer AG
  • bioMérieux SA
  • Biosynth Ltd.
  • Cardinal Health, Inc.
  • Cerebral Therapeutics, Inc.
  • Clarity Pharmaceuticals
  • Curasight A/S
  • Curium Inc.
  • Evergreen Theragnostics, Inc.
  • GE HealthCare Technologies, Inc.
  • Hermes Medical Solutions AB
  • Icon Group
  • Indi Molecular, Inc.
  • Integrated Clinical Oncology Network Pty Ltd.
  • Invicro, LLC
  • Ipsen Pharma
  • Radiopharm Theranostics Limited
  • Ratio Therapeutics
  • Siemens Healthineers AG
  • SOFIE Co.
  • Telix Pharmaceuticals Limited
  • United Theranostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.18 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028 - Product Image

Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Forecast to 2028

  • Report
  • 194 Pages
  • Global
From
Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 239 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical Theranostics Global Market Report 2024 - Product Image

Radiopharmaceutical Theranostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Theranostics Global Market Report 2024 - Product Image

Theranostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.